Contingencies - Additional Information (Details) - USD ($)			12 Months Ended
	Jan. 26, 2022	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loss Contingencies [Line Items]
Revenues			$ 104,566,000	$ 57,635,000
Gain loss related to litigation settlement		$ 3,768,000	3,768,000
Reclassed to accrued expenses and other current liabilities			1,200,000
Long term Contingent consideration		2,393,000	2,393,000	3,103,000
Accretion expense			505,000	758,000
Payment and Settlements of contingencies			1,201,000	1,500,000
Notes issued			485,000
Shares issued			722,000
Subsequent Event [Member]
Loss Contingencies [Line Items]
Loss contingency damages sought value	$ 19,000,000
Loss Contingency Benefit Value	$ 129,000,000
Om of Medicine
Loss Contingencies [Line Items]
Increase contingent liability				774,000
Reclassed to accrued expenses and other current liabilities			1,200,000
Long term Contingent consideration		2,393,000	2,393,000
Accretion expense			505,000	$ 758,000
Payment and Settlements of contingencies			1,201,000
Notes issued			485,000
Shares issued			722,000
Om of Medicine | Revenue Milestone One
Loss Contingencies [Line Items]
Probability increase in percentage terms of the milestone revenue to be attained				100.00%
Om of Medicine | Revenue Milestone One | Minimum
Loss Contingencies [Line Items]
Revenues			3,400,000
Om of Medicine | Revenue Milestone Two | Minimum
Loss Contingencies [Line Items]
Revenues			3,500,000
Om of Medicine | Revenue Milestone Two | Maximum
Loss Contingencies [Line Items]
Business combination contingent consideration payable		$ 6,000,000	$ 6,000,000
Pure Ratios
Loss Contingencies [Line Items]
Contingent consideration earned					$ 750,000
Contingent consideration stock issued per an amendment to the agreement					94,000
Reduction in note receivable from contingent consideration					$ 656,000
Contingent consideration additional earned				$ 750,000
Payment and Settlements of contingencies				1,500,000
Amount due recorded in accounts payable				$ 167,000
Pure Ratios | Common Class A [Member]
Loss Contingencies [Line Items]
Number of shares issued as a settlement of consideration			473,491